Andrea Lenzi to Hyperlipidemias
This is a "connection" page, showing publications Andrea Lenzi has written about Hyperlipidemias.
Connection Strength
0.148
-
Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia. Diabetes Res Clin Pract. 2018 Sep; 143:428-431.
Score: 0.148
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.